Ireland
--:--IST
Recruiting Observational

Neuroplasticity After Proprioceptive Rehabiliation

NCT05277519 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2022-06-16
Last updated
2026-07-07

Condition(s) studied

StrokeHemiparesisTraumatic Brain Injury

Investigational drug(s) / intervention(s)

Vibrations

Vibrations: Sequenced muscle vibrations during 30 min., 3 times a week during 5 weeks

Study summary

Sequences of muscle tendon vibrations allow to reproduce the sensory feedback during movement like locomotion and kinaesthesia. It is known that such a treatment promotes motor recovery after stroke assuming that it enhances neuroplasticity. The aim of the research is to study the activity in cerebrospinal circuitry to evaluate the neuroplastic changes during and after instrumented proprioceptive rehabilitation relying on sequences of muscle vibration in subacute stroke stages.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * hemiparesis at least transient in lower limb following an acquired brain injury (stroke or traumatic brain injury) * French spoken * Affiliated to a French social insurance * No previous traumatic, vascular or neurodegenerative injuries * Having presented during the acute phase or presenting a motor deficit of one of the lower limbs * Presenting an absence of autonomy of walking at the entrance of the rehabilitation department * In the sub-acute phase, i.e. from 15 days to 6 months after the accident * Presenting moderate cognitive disorders allowing them to understand instructions and give their consent Exclusion Criteria: * strong cognitive disorders * maintenance of justice, tutelage, legal guardianship * Pregnancy and breastfeeding * Outpatients who do not have weekly follow-up in the rehabilitation department

Primary outcome measure(s)

  • Baseline EMG — Evaluation at baseline (4 days before treatment)
    H-reflex and reciprocal inhibition
  • Baseline EEG — Evaluation at baseline (4 days before treatment)
    SEP and resting state activity
  • EMG change from baseline after 2-week treatment — Evaluation during the 3rd week of treatment
    H-reflex and reciprocal inhibition
  • EEG change from baseline after 2-week treatment — Evaluation during the 3rd week of treatment
    SEP and resting state activity
  • EMG change after the 5-week treatment — Evaluation 4 days after the end of the 5-week treatment
    H-reflex and reciprocal inhibition
  • EEG change after the 5-week treatment — Evaluation 4 days after the end of the 5-week treatment
    SEP and resting state activity

Trial sites (1)

FacilityCityRegionStatus
Pitié-Salpêtrière Hospital Paris France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05277519 on ClinicalTrials.gov ↗ ← All trials in France